FOGLIETTA, MYRIAM
 Distribuzione geografica
Continente #
NA - Nord America 2.229
EU - Europa 1.370
AS - Asia 730
AF - Africa 38
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 5
Totale 4.395
Nazione #
US - Stati Uniti d'America 2.204
CN - Cina 409
DE - Germania 219
IT - Italia 216
SG - Singapore 192
AT - Austria 181
SE - Svezia 167
IE - Irlanda 148
UA - Ucraina 109
FR - Francia 101
FI - Finlandia 78
KR - Corea 44
GB - Regno Unito 37
PL - Polonia 35
SN - Senegal 31
VN - Vietnam 31
NL - Olanda 26
CA - Canada 24
IN - India 15
AU - Australia 14
RU - Federazione Russa 14
ID - Indonesia 10
JP - Giappone 10
BE - Belgio 8
BY - Bielorussia 8
EU - Europa 8
ES - Italia 6
GR - Grecia 6
HK - Hong Kong 6
UZ - Uzbekistan 6
CH - Svizzera 3
ZA - Sudafrica 3
AR - Argentina 2
RO - Romania 2
TW - Taiwan 2
A1 - Anonimo 1
BW - Botswana 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
TG - Togo 1
TR - Turchia 1
UY - Uruguay 1
Totale 4.395
Città #
Chandler 304
Beijing 281
Santa Clara 205
Vienna 180
Dublin 147
Singapore 147
Fairfield 112
Ashburn 107
Houston 96
Jacksonville 94
Nyköping 80
Dearborn 79
Ann Arbor 69
Torino 67
Villeurbanne 62
Medford 58
Wilmington 49
Woodbridge 49
Princeton 46
Fremont 42
Seattle 41
Columbus 40
Cambridge 38
San Mateo 35
Warsaw 30
Pisa 28
Washington 27
Turin 23
Guangzhou 19
Milan 19
Toronto 19
Redwood City 18
Phoenix 17
New York 15
Dong Ket 13
Mountain View 12
Nürnberg 12
Nanjing 10
Jakarta 9
Boardman 8
Brussels 8
Düsseldorf 8
Hefei 8
Norwalk 8
Rotterdam 8
Shanghai 8
Boston 7
San Jose 7
Changsha 6
Kunming 6
Munich 6
Pune 6
Adelaide 5
Chengdu 5
Hangzhou 5
Liverpool 5
Nanchang 5
Tokyo 5
Dronten 4
Jinan 4
San Diego 4
Central District 3
Groningen 3
Heidelberg 3
Johannesburg 3
Limoges 3
Ottawa 3
Philadelphia 3
Provo 3
Tianjin 3
Wuhan 3
Zhengzhou 3
Brescia 2
Bucharest 2
Buffalo 2
Buscate 2
Central 2
Chieri 2
Costa Mesa 2
Curcuris 2
Deiva Marina 2
Den Haag 2
Erlangen 2
Fuzhou 2
Genoa 2
Helsinki 2
Kharkiv 2
Los Angeles 2
Los Corrales de Buelna 2
Matera 2
Melbourne 2
Nanning 2
New Delhi 2
New Haven 2
Nichelino 2
Palermo 2
Paris 2
Pittsburgh 2
Quzhou 2
Québec 2
Totale 2.924
Nome #
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells 283
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells 256
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma 203
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. 202
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells 162
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 145
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL) 133
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 132
Vγ9Vδ2 T cells as strategic weapons to improve the potency of immune checkpoint blockade and immune interventions in human myeloma 123
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression 120
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells 113
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 110
Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma 109
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy 107
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 104
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) 100
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: Diagnostic challenges and therapeutic options: Two case reports 99
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells 95
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespective of the disease status. 92
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method 91
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions 88
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients. 88
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma 87
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma 87
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. 87
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. 86
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 86
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID 84
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 84
Distribution of γδ T cells in patients with hematological malignancies 83
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells 82
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 81
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells 79
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity upon short-term incubation with zoledronic acid 77
The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells 75
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 72
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 70
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. 65
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases 54
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma 43
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. 37
Totale 4.551
Categoria #
all - tutte 13.189
article - articoli 0
book - libri 0
conference - conferenze 5.969
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020392 0 0 0 0 0 105 81 38 32 67 32 37
2020/2021501 44 49 29 11 70 18 27 30 44 33 81 65
2021/2022624 31 5 11 39 18 9 107 34 14 79 175 102
2022/2023820 83 84 21 85 72 190 45 53 87 27 45 28
2023/2024348 35 76 37 13 21 79 4 18 0 12 11 42
2024/2025511 4 29 45 78 315 40 0 0 0 0 0 0
Totale 4.551